High-Fructose Corn Syrup-Sweetened Soft Drink Consumption Increases Vascular Resistance in the Kidneys at Rest and During Sympathetic Activation
-
2020/04/01
-
Details
-
Personal Author:Bloomfield AC ; Chapman CL ; Grigoryan T ; Johnson BD ; Kueck PJ ; Pietrafesa LD ; Reed EL ; Schlader ZJ ; Vargas NT
-
Description:We first tested the hypothesis that consuming a high-fructose corn syrup (HFCS)-sweetened soft drink augments kidney vasoconstriction to sympathetic stimulation compared with water (study 1). In a second study, we examined the mechanisms underlying these observations (study 2). In study 1, 13 healthy adults completed a cold pressor test, a sympathoexcitatory maneuver, before (preconsumption) and 30 min after drinking 500 mL of decarbonated HFCS-sweetened soft drink or water (postconsumption). In study 2, venous blood samples were obtained in 12 healthy adults before and 30 min after consumption of 500 mL water or soft drinks matched for caffeine content and taste, which were either artificially sweetened (Diet trial), sucrose-sweetened (Sucrose trial), or sweetened with HFCS (HFCS trial). In both study 1 and study 2, vascular resistance was calculated as mean arterial pressure divided by blood velocity, which was measured via Doppler ultrasound in renal and segmental arteries. In study 1, HFCS consumption increased vascular resistance in the segmental artery at rest (by 0.5 +/- 0.6 mmHg·cm-1·s-1, P = 0.01) and during the cold pressor test (average change: 0.5 +/- 1.0 mmHg·cm-1·s-1, main effect: P = 0.05). In study 2, segmental artery vascular resistance increased in the HFCS trial (by 0.8 +/- 0.7 mmHg·cm-1·s-1, P = 0.02) but not in the other trials. Increases in serum uric acid were greater in the HFCS trial (0.3 +/- 0.4 mg/dL, P = 0.04) compared with the Water and Diet trials, and serum copeptin increased in the HFCS trial (by 0.8 +/- 1.0 pmol/L, P = 0.06). These findings indicate that HFCS acutely increases vascular resistance in the kidneys, independent of caffeine content and beverage osmolality, which likely occurs via simultaneous elevations in circulating uric acid and vasopressin. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1931-857X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:318
-
Issue:4
-
NIOSHTIC Number:nn:20060306
-
Citation:Am J Physiol Renal Physiol 2020 Apr; 318(4):F1053-F1065
-
Contact Point Address:Zachary J. Schlader, Department of Kinesiology, Indiana University, Room 112, 1025 E. 7th St., Bloomington, IN 47405
-
Email:zschlade@indiana.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2020
-
NORA Priority Area:
-
Performing Organization:Indiana University, Bloomington
-
Peer Reviewed:True
-
Start Date:20190901
-
Source Full Name:American Journal of Physiology: Renal Physiology
-
End Date:20240831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:774de0811b5bbf1de2567c8939b91112268cd3a57a35524685da0dad895fc16522a7c06cd6281806721417e1b2c7df2b7c32f0d445021992c050e47ee99bd5d5
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like